Amid shortages and another recall, Abbott plans $500 million infant formula plant
"This country would benefit from more manufacturing capacity and redundancy," the health care company's CEO said.
Stay updated with breaking news from Similac Pro Total. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"This country would benefit from more manufacturing capacity and redundancy," the health care company's CEO said.
"This country would benefit from more manufacturing capacity and redundancy," the health care company's CEO said.
Abbott says it won't affect the U.S. infant formula supply.
MONDAY, Oct. 17, 2022 (HealthDay News) -- Abbott Inc. has announced that it is again recalling some of its infant formula products, though the company said this latest recall is
On Friday, Abbott , the largest formula manufacturer in the U.S., issued a recall of some formula for infants and kids, saying the caps on the bottles may be defective,